• Skyrizi bags positive psoriatic arthritis results pharmatimes
    January 08, 2021
    AbbVie and Boehringer Ingelheim’s Skyrizi (risankizumab) has scored positive top-line results from two phase III studies in adults with active psoriatic arthritis.
PharmaSources Customer Service